Immunome, Inc. employees and revenue per employee

IMNM · Biotechnology · $2.22B market cap

Immunome, Inc. had 177 employees at the end of fiscal Dec 2025, up 50.0% from a year earlier. Revenue for the year was $6.9M, down 23.2% from a year earlier, or $39K per employee. Revenue fell while headcount grew.

Employees

177

+50.0% YoY

Revenue

$6.9M

-23.2% YoY

Revenue / employee

$39K

Peer median $457K

Rank in industry

98 of 110

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2023
28186344'23'24'25Revenue 50Staff 322

Hover a year for the numbers.

IMNM employees and revenue by fiscal year
Year endingEmployeesRevenuePer employeeStaff YoYRevenue YoY
Dec 2025177$6.9M$39K+50.0%-23.2%
Dec 2024118$9.0M$77K+114.5%-35.5%
Dec 202355$14.0M$255K——

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years
55'23118'24177'25
Revenue per employee, last six fiscal years
$255K'23$77K'24$39K'25

Immunome, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

CompanyEmployeesRevenueRevenue / employeeShape
CBIO
Crescent Biopharma, Inc.
44$10.8M$246K—
JANX
Janux Therapeutics, Inc.
109$10.0M$92KHiring into decline
PRAX
Praxis Precision Medicines, Inc.
116$8.6M$74KEfficient growth
PGEN
Precigen, Inc.
160$9.7M$61KEfficient growth
ZBIO
Zenas BioPharma, Inc.
167$10.0M$60KEfficient growth
IMNM
Immunome, Inc.
177$6.9M$39KHiring into decline
CGON
CG Oncology Inc.
142$4.0M$28KEfficient growth
CRNX
Crinetics Pharmaceuticals, Inc.
594$7.7M$13KEfficient growth
AKTS
Aktis Oncology, Inc.
200,000$6.5M$32—
Every Healthcare company

Questions about Immunome, Inc.

How many employees does Immunome, Inc. have?
Immunome, Inc. reported 177 employees for the fiscal year ending Dec 2025, in the annual report it filed on March 3, 2026. That is up 50.0% from a year earlier.
What is Immunome, Inc.'s revenue per employee?
Immunome, Inc. brought in $6.9M of revenue in fiscal Dec 2025, which is $39K per employee. That ranks 98 of 110 companies we track in Biotechnology, where the median is $457K.
Where do these numbers come from?
Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

This page is the filings. The research is a membership.

On the first and third Friday of each month Outpick publishes one stock pick with the full case for owning it, adds it to a live portfolio you can audit, and writes a note when a position closes. A new account gets 21 days of the whole membership with no card, and nothing is charged when it ends.

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

Compare IMNM with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Source: employee counts and revenue as stated in Immunome, Inc.'s annual reports (Form 10-K), latest filed March 3, 2026. This is data, not a recommendation to buy or sell IMNM.